Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Camidanlumab tesirine |
| Trade Name | |
| Synonyms | ADCT-301|ADCT 301|ADCT301 |
| Drug Descriptions |
Camidanlumab tesirine (ADCT-301) is a human monoclonal antibody against CD25 linked to pyrrolobenzodiazepine dimer toxin, which may specifically target CD25-positive tumor cells (Blood 2017 130(Suppl 1):1510, PMID: 32521310, PMID: 32912922). |
| DrugClasses | |
| CAS Registry Number | 1853239-04-9 |
| NCIT ID | C121949 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Camidanlumab tesirine | Camidanlumab tesirine | 0 | 4 |